Ino K - Search Results

1

Association between CYP19A1 polymorphisms and sex hormones in postmenopausal Japanese women.

Kidokoro K, Ino K, Hirose K, Kajiyama H, Hosono S, Suzuki T, Kawase T, Hiraki A, Hamajima N, Tanaka H, Tajima K, Kikkawa F, Matsuo K. Kidokoro K, et al. Among authors: ino k. J Hum Genet. 2009 Feb;54(2):78-85. doi: 10.1038/jhg.2008.11. Epub 2009 Jan 16. J Hum Genet. 2009. PMID: 19158807

2

Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity.

Umezu T, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A, Kikkawa F. Umezu T, et al. Among authors: ino k. Hum Cell. 2007 Aug;20(3):71-6. doi: 10.1111/j.1749-0774.2007.00030.x. Hum Cell. 2007. PMID: 17645726

3

Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.

Fujiwara S, Nawa A, Nakanishi T, Shimoyama Y, Kajiyama H, Shibata K, Ino K, Nakamura S, Kikkawa F, Yatabe Y. Fujiwara S, et al. Among authors: ino k. Hum Pathol. 2010 Apr;41(4):560-5. doi: 10.1016/j.humpath.2009.09.010. Epub 2009 Dec 11. Hum Pathol. 2010. PMID: 20004952

4

Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.

Kajiyama H, Kikkawa F, Suzuki T, Shibata K, Ino K, Mizutani S. Kajiyama H, et al. Among authors: ino k. Cancer Res. 2002 May 15;62(10):2753-7. Cancer Res. 2002. PMID: 12019149

5

Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma.

Khin EE, Kikkawa F, Ino K, Suzuki T, Shibata K, Kajiyama H, Tamakoshi K, Mizutani S. Khin EE, et al. Among authors: ino k. Int J Gynecol Pathol. 2003 Apr;22(2):175-80. doi: 10.1097/00004347-200304000-00010. Int J Gynecol Pathol. 2003. PMID: 12649673

6

Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade.

Kajiyama H, Kikkawa F, Ino K, Shibata K, Mizutani S. Kajiyama H, et al. Among authors: ino k. Adv Exp Med Biol. 2003;524:245-8. doi: 10.1007/0-306-47920-6_29. Adv Exp Med Biol. 2003. PMID: 12675245 No abstract available.

7

Adhesion potency to mesothelial cells by overexpression of dipeptidyl peptidase IV.

Kikkawa F, Kajiyama H, Ino K, Shibata K, Mizutani S. Kikkawa F, et al. Among authors: ino k. Adv Exp Med Biol. 2003;524:249-52. doi: 10.1007/0-306-47920-6_30. Adv Exp Med Biol. 2003. PMID: 12675246 No abstract available.

8

Survival time and invasive activity due to dipeptidyl peptidase IV overexpression in ovarian carcinoma.

Mizutani S, Kajiyama H, Suzuki T, Shibata K, Ino K, Kikkawa F. Mizutani S, et al. Among authors: ino k. Adv Exp Med Biol. 2003;524:253-6. doi: 10.1007/0-306-47920-6_31. Adv Exp Med Biol. 2003. PMID: 12675247 No abstract available.

9

Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma.

Suzuki Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Nomura S, Tsujimoto M, Mizutani S. Suzuki Y, et al. Among authors: ino k. Clin Cancer Res. 2003 Apr;9(4):1528-34. Clin Cancer Res. 2003. PMID: 12684429

10

Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.

Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S. Kajiyama H, et al. Among authors: ino k. Cancer Res. 2003 May 1;63(9):2278-83. Cancer Res. 2003. PMID: 12727850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters